HIF1A and central nervous system cancer: Studies in GB tissue showed that HIF-1α immunoreactivity is particularly strong in areas surrounding necrosis that is predominantly in the nuclei, while in low-grade gliomas, HIF-1α expression is predominantly located in the cytosol [81,83].